MedTrace Logo

The Combination Therapy of Nanofat Grafting and PRP Compared With Microfat Grafting and PRP Synergy in Treating Striae Distensae

NCT03807986 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-01-17

No results posted yet for this study

Summary

Striae distensae is caused by the fracture and damage of the elastic fibers and collagen fibers, which is still a difficulty to overcome. Based on the studies demonstrated that platelet-rich plasma(PRP) has positive effect on superficial scar, and nanofat and microfat are effective in treating atrophic scar. So in this clinical trial, the investigators are going to treat striae distensae by using two combination therapies. One is nanofat grafting and PRP injection synergy, and the other one is treated by microfat grafting with PRP injection.

Conditions

  • Treatments of Striae Distensae

Interventions

PROCEDURE

Nanofat grafting

Nanofat grafting will be applied once every three months for 2 times.

PROCEDURE

Microfat grafting

Microfat grafting will be applied once every three months for 2 times.

PROCEDURE

Platelet-rich plasma (PRP) Injection

PRP Injection will be applied once a month for 6 times.

Sponsors & Collaborators

  • Science and Technology Program of Guangzhou,Guangzhou Sipintang Biological technology Co., Ltd.

    collaborator UNKNOWN

  • First Affiliated Hospital of Jinan University

    lead OTHER

Principal Investigators

  • Li Ling Xiao, MD · First Affiliated Hospital of Jinan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-01
Primary Completion
2019-05-01
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03807986 on ClinicalTrials.gov